Vaccine Investment Portfolios

Bavarian Nordic's Smallpox Vaccine Shows 58% Effectiveness Against Mpox, Study Reveals Sep 13, 2024

India Poised for Dengue Vaccine by 2026 as Takeda Commences Trials Jul 25, 2024

Valneva Announces European Green Light for First Chikungunya Vaccine, IXCHIQ® Jul 1, 2024

Valneva Commences Pediatric Trial for Single-Dose Chikungunya Vaccine Jan 11, 2024

Valneva's Single-Dose Vaccine Shows Long-term Antibody Response Dec 8, 2023